Clinical Trials Browser

Not yet recruiting × Colorectal Neoplasms × Trastuzumab × Clear all

NCT06589830 2025-05-15

TL938 and Trastuzumab for Patients With HER2-positive Metastatic Colorectal Cancer

Phase 2 Not yet recruiting

Gastrointestinal

Neoplasms, Colorectal Neoplasms